» Rat Guide     » Health Guide     » Care Guide     » Medication Guide     » Breeding Guide    

Butorphanol Tartrate

Analgesics
Back to Analgesics

Brand

Torbutrol, Torbugesic, Stadol

Availability

Torbutrol injectable: 0.5 mg/mL in 10 mL vials
Torbutrol tablets: 1 mg, 5 mg & 10 mg
Torbugesic injectable: 10 mg/mL in 50 mL vials
Stadol injectable: 1 mg/mL & 2 mg/mL

Pharmacology

Butorphanol is a synthetic partial opiate agonist that is structurally related to Morphine. It is a more potent analgesic than Morphine, but unlike Morphine it possess less cardiovascular effects, and respiratory center sensitivity.

It’s actions are similar to that of other partial agonists such as, pentazocine or nalbuphine. The agonist activity of butorphanol is believed to be exerted at the kappa and sigma receptors.

Butorphanol binds to opiate receptors at sites in the central nervous system and alters perception and response to pain. It also has the ability to act as an antitussive.

Duration of action following dose appears to be 4 hours.

It is absorbed in the gut with its highest distribution levels being in the kidney, liver, and intestine. Levels throughout other tissues are found to be higher than plasma. The drug is metabolized in the liver, crosses placental barrier, and distributed into breast milk. It is excreted in urine and bile, and eliminated in the feces.

Safety in pregnant and very young animals has not been determined.

Indications

Used as an analgesic and a sedative.

Drug Interactions or Contraindications

Incompatible mixed with dimenhydrinate and pentobaritol sodium.

Use cautiously in hypothyroidism, severe renal insufficiency, or severely debilitated.

Butorphanol, if used with other central nervous system depressants may increase the CNS or respiratory depression of those drugs. It is recommended to decrease butorphanol’s dosage if used in conjunction with those particular drugs.

Adverse Reactions

CNS: sedation, confusion, lethargy, agitation.
CV:  bradycardia

Respiratory:  decreased respiratory rate

GI:  constipation

GU:  urinary retention

Skin:  itching

Other:  In the event of signs of overdose, such as cardiac and respiratory depression, administer naloxone 0.01 to 0.10 mg/kg SC, IP (narcotic reversal) (1), fluids, O2, and vasopressors.

Dosage Recommendations

0.5 mg/kg to 2 mg/kg , SQ , q6hrs  2

or

1 mg/kg to 5 mg/kg , SQ , q2hrs to q4hrs   1(Sedation)

or

0.18 mg/lb to 10 mg/lb SQ , or 1 mg/lb , PO , q4hrs to q6hrs   3

or

0.25 mg/lb to 1 mg/lb , SQ (effective for pain)   3

or

When combined with diazepam: 0.25 mg/lb butorphanol and 1 mg/lb diazepam.   3

Considerations

  • Note to veterinarians: the chance of rats developing pica following the use of butorphanol may be less than it is with buprenorphine due to butorphanol’s short duration of action.
    However, it is advised to instruct pet owners to monitor for this behavior if an opioid medication is given, and to contact vet immediately. Also have the pet owner remove the rat from any bedding source that might be chewed and ingested until medication has passed through the system.
    It is also important to be aware that pica may be observed, in rats, where pain has not been adequately addressed.
  • Store at room temperature away from light.

Posted on June 23, 2003, 14:43, Last updated on May 24, 2013, 07:21 | Analgesics



Rat Guide Logo
All other written and visual materials used by permission of specific authors for the sole use of the Rat Guide.
Brought to you by KuddlyKorner4u
See Logos page for linking to the Rat Guide.
Rat Guide brought to you by KuddlyKorner4u